Poo transplant shows promise as treatment for peanut allergy

In the news:

• In a small study, participants with a peanut allergy swallowed capsules containing treated faecal matter, and tried a dose of peanut four months later. Some were able to tolerate the peanut without a reaction.
• CEO of Eli Lilly discusses barriers to getting their GLP-1 agonist medication listed on the PBS, and questions the veracity of the process for getting the most up to date medications to Australian patients.
• The President of the United States signed an executive order changing the childhood vaccine schedule, making a link to autism, despite evidence to the contrary.

References

• Nature: First poo transplant to treat food allergy in people has ‘exciting’ results
• Eli Lilly CEO still wants deal to bring Mounjaro to Australia under PBS
• Trump signs order to reduce childhood vaccines and break up MMR shots